Company Profile

Umech Technologies LLC
Profile last edited on: 1/7/2024      CAGE: 7ENZ4      UEI: YA1HNMNA7K39

Business Identifier: Automated imaging instruments for biology
Year Founded
1999
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

25 Clarendon Street
Watertown, MA 02472
   (617) 923-2942
   N/A
   www.umech.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Umech Technologies is focused to development of optical instruments for high throughput and high content cell imaging. The firm's Cytovar is a complete instrument for cell-based assay measurement, combining the capabilities of a plate reader, imaging cytometer, and high content imager in a single, compact chassis. With an interface designed for ease of use and a scalable architecture, scientists can develop their assays quickly and then take them seamlessly to much higher throughput using a turn-key Cytovar cluster. Umech Technologies design and manufacture optical scientific instruments involving imaging, illumination, and computation often involving custom sensors, modulators, electronics, and opto-mechanics. Micro- and nano-scale optical profile and vibration measurements, and digital micro-imaging for probing environments.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NIH $327,701
Project Title: 3d Tessellation Imaging
2016 1 NSF $225,000
Project Title: Plate-scale liquid handling robotics

Key People / Management

  Charles Abnet -- VP Research and Development

  Michael Mermelstein

Company News

There are no news available.